Healthcare provider profile · identity verified

Anna L. Armedilla, MD

Family Practice · HARBOR CITY, CA · NPI 1720136732

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	242
Amlodipine Besylate	Amlodipine Besylate	446	190
Losartan Potassium	Losartan Potassium	394	163
Rosuvastatin Calcium	Rosuvastatin Calcium	273	112
Potassium Chloride	Potassium Chloride	267	104
Lisinopril	Lisinopril	243	109
Hydrochlorothiazide	Hydrochlorothiazide	241	97
Levothyroxine Sodium	Levothyroxine Sodium	221	85
Albuterol Sulfate Hfa	Albuterol Sulfate	210	110
Gabapentin	Gabapentin	201	82
Simvastatin	Simvastatin	191	77
Metformin Hcl	Metformin Hcl	178	73
Metformin Hcl Er	Metformin Hcl	153	68
Metoprolol Tartrate	Metoprolol Tartrate	149	64
Meloxicam	Meloxicam	129	66
Atenolol	Atenolol	127	50
Omeprazole	Omeprazole	120	63
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	116	49
Allopurinol	Allopurinol	115	45
Jardiance	Empagliflozin	109	50
Glipizide	Glipizide	105	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	32
Pantoprazole Sodium	Pantoprazole Sodium	88	34
Hydralazine Hcl	Hydralazine Hcl	86	43
Alendronate Sodium	Alendronate Sodium	80	33
Hydrocortisone	Hydrocortisone	70	37
Triamcinolone Acetonide	Triamcinolone Acetonide	70	41
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	26
Trazodone Hcl	Trazodone Hcl	61	26
Doxycycline Monohydrate	Doxycycline Monohydrate	60	55
Famotidine	Famotidine	56	27
Furosemide	Furosemide	50	24
Alvesco	Ciclesonide	46	20
Clopidogrel	Clopidogrel Bisulfate	46	23
Ozempic	Semaglutide	46	11
Terazosin Hcl	Terazosin Hcl	45	16
Humulin N Kwikpen	Insulin Nph Human Isophane	43	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	24
Pradaxa	Dabigatran Etexilate Mesylate	41	17
Duloxetine Hcl	Duloxetine Hcl	40	20
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	39	39
Ciclopirox	Ciclopirox	39	27
Bisoprolol Fumarate	Bisoprolol Fumarate	38	13
Sertraline Hcl	Sertraline Hcl	38	16
Acetaminophen-Codeine	Acetaminophen With Codeine	37	17
Lorazepam	Lorazepam	36	15
Tamsulosin Hcl	Tamsulosin Hcl	34	20
Ezetimibe	Ezetimibe	33	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	18
Lactulose	Lactulose	32	16
Fluticasone Propionate	Fluticasone Propionate	31	17
Pravastatin Sodium	Pravastatin Sodium	28	11
Fluconazole	Fluconazole	26	26
Humulin N	Insulin Nph Human Isophane	26	11
Lovastatin	Lovastatin	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	17
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Cefadroxil	Cefadroxil	23	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	11
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Spironolactone	Spironolactone	22	12
Acyclovir	Acyclovir	21	13
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Amoxicillin	Amoxicillin	20	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Clonazepam	Clonazepam	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	11
Glipizide Er	Glipizide	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Metronidazole	Metronidazole	13	12
Ofloxacin	Ofloxacin	13	12
Colchicine	Colchicine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Finasteride	Finasteride	12	suppressed
Ibuprofen	Ibuprofen	12	11
Morphine Sulfate	Morphine Sulfate	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Victoza 2-Pak	Liraglutide	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cephalexin	Cephalexin	11	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Temazepam	Temazepam	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error